Organization
Rheumatology, Leeds General Infirmary, Leeds, United Kingdom, Division of Rheumatology, Stanford University Medical Center, Palo Alto, Department of Rheumatology, Allergy, and Immunology, UCSD Center for Innovative Therapy, La Jolla, Southwestern Medical Center, University of Texas, Dallas, Immunology, Abbott Laboratories, Parsippany, Immunology, Abbott Laboratories, Abbott Park, United States
2 abstracts
Abstract
ADALIMUMAB PLUS METHOTREXATE RESULTS IN LESS FREQUENT AND LESS SEVERE RADIOGRAPHIC PROGRESSION THAN METHOTREXATE ALONE AT ALL LEVELS OF CLINICAL RESPONSE IN EARLY RHEUMATOID ARTHRITISOrg: Rheumatology, Leeds General Infirmary, Leeds, United Kingdom, Division of Rheumatology, Stanford University Medical Center, Palo Alto, Department of Rheumatology, Allergy, and Immunology, UCSD Center for Innovative Therapy, La Jolla, Southwestern Medical Center, University of Texas, Dallas, Immunology, Abbott Laboratories, Parsippany, Immunology, Abbott Laboratories, Abbott Park, United States,
Abstract
AUTOANTIBODY-POSITIVE RHEUMATOID ARTHRITIS (RA) PATIENTS (PTS) HAVE ENHANCED CLINICAL RESPONSE TO RITUXIMAB (RTX) WHEN COMPARED WITH SERONEGATIVE PATIENTS Org: Musculoskeletal Research Group, ICM, Newcastle University, Newcastle Upon Tyne, United Kingdom, Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, United States, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands, Rheumatology, Oregon Health & Science University, Portland, United States, Rheumatology, University of Toronto, Toronto, Canada,